On Nov 05, 2025, EHAB reported earnings of 0.17 USD per share (EPS) for Q3 25, beating the estimate of 0.12 USD, resulting in a 38.89% surprise. Revenue reached 263.60 million, compared to an expected 272.52 million, with a -3.27% difference. The market reacted with a -6.09% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of 0.14 USD, with revenue projected to reach 275.97 million USD, implying an decrease of -17.65% EPS, and increase of 4.69% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
FAQ
What were Enhabit, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Enhabit, Inc. reported EPS of $0.17, beating estimates by 38.89%, and revenue of $263.60M, -3.27% below expectations.
How did the market react to Enhabit, Inc.'s Q3 2025 earnings?
The stock price moved down -6.09%, changed from $8.21 before the earnings release to $7.71 the day after.
When is Enhabit, Inc. expected to report next?
The next earning report is scheduled for Mar 03, 2026.
What are the forecasts for Enhabit, Inc.'s next earnings report?
Based on 7
analysts, Enhabit, Inc. is expected to report EPS of $0.14 and revenue of $275.97M for Q4 2025.